Joaquina Baranda, M.D., leads the KU Cancer Center’s early-phase clinical trial program, which is the first step in taking new therapies from the research lab to the patient
Decades of basic (or bench) science has built the foundational knowledge needed to make advancements in the diagnosis, treatment and prevention of diseases, including cancer. That preclinical research has led to early-phase clinical trials and today’s leading-edge cancer treatments at The University of Kansas Cancer Center.
Dr. Jeff Burns and Dr. Russ Swerdlow, directors of the University of Kansas Alzheimer’s Disease Center, are exploring a variety of interventions to prevent, delay and treat Alzheimer’s disease at the KU Clinical Research Center in Fairway, Kansas.
Just about everyone knows someone who has been affected by Alzheimer’s disease and other dementias. These age-related conditions affect an estimated 5.6 million Americans, including 50,000 Kansans.
Justin Carroll, KUEC Biotechnology grad, attributes his on-the-job technical and problem-solving skills related to COVID-19 testing to his education at the KU Edwards Campus.
It’s not unusual for college students to balance their classroom education with real-life workplace experience. For 23-year-old Justin Carroll, a KU Edwardsbiotechnology senior, on-the-job experience has recently taken on a greater level importance.